Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teck Resources Ord Shs Class A T.TECK.A

Alternate Symbol(s):  TCKRF | TECK | T.TECK.B

Teck Resources Limited is a Canadian resource company. The Company operates a portfolio of copper and zinc operations across North and South America. The Company’s operations and projects include Antamina, Cardinal River, Galore Creek Project, Carmen de Andacollo, Highland Valley Copper, Trail Operations, Quebrada Blanca, Carmen de Andacollo, HVC Mine Life Extension Project, Galore Creek Project, NorthMet Project, Mesaba Project, NuevaUnion Project, Red Dog, Sullivan Mine and Trail Operations. The Antamina mine is a copper and zinc mine, located in the Andes Mountain range, 270 kilometers north of Lima, Peru. The deposit is located at an average elevation of 4,200 meters. Its Carmen de Andacollo is located in the Coquimbo Region of central Chile at an elevation of 1,000 meters, approximately 350 kilometers north of Santiago. Its Galore Creek is located within the territory of the Tahltan in northwestern British Columbia, approximately 150 kilometers northwest of Stewart.


TSX:TECK.A - Post by User

Post by Moonshiner592on Mar 07, 2021 8:01am
285 Views
Post# 32738104

Looking to diversify your portfolio?

Looking to diversify your portfolio?

Check out Claritaspharma - Ticker: V.Kly 

FYI - Their principal product (R107) being developed to fight COVID is not only resistant to all its mutations... but it also can fight any other RNA encoded virus .. such as the common cold and flu .. Hepatitis C and E .. polio .. Ebola .. measles 

With their worldwide patent for R107 ... they can get massive! 

Lots more to read (ie. about interpretations of PR's ect) on Kalyteran.co

<< Previous
Bullboard Posts
Next >>